To enhance your experience, with your consent for all our websites and applications, we (and our partners) store and/or access information on your device (cookies or corresponding information) when you connect. Our website may use these cookies to:
Determine the audience of advertisements on our website without collecting data
Display personalized ads based on your browsing and profile
Personalize our editorial content according to your navigation
Allow you to share content on social networks or platforms on our website
Send you ads based on your location
Accept All
Reject All
Home > Volumes and issues > Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer
2121 views 1598 downloads
Review Articie 28 September 2023
Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer
Haoyu An 1
,  Zhiheng Qiu 2 ,  Yukun Zhou 3
show author's information
DOI: 10.55578/joaims.230918.001
Keywords: Health informatics; Artificial intelligence; Healthcare data; Machine learning; Deep learning; Health information systems; Patient care; Systematic review
Cite this article: An H, Qiu Z, Zhou Y (2023) Advances in Radiomics to Assess Immunotherapy Associated with Efficacy and Adverse Events for Non-small Cell Lung Cancer. Journal of Artificial Intelligence for Medical Sciences, 4(2), 47-52, 2023.
Full Text PDF
Download Citation